Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($) $ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2016 |
Jun. 30, 2015 |
Jun. 30, 2016 |
Jun. 30, 2015 |
Cash flows from operating activities: |
|
|
|
|
Net loss |
$ (39,822)
|
$ (13,934)
|
$ (135,657)
|
$ (10,156)
|
Adjustments to reconcile net income (loss) |
|
|
|
|
Depreciation and amortization |
36,317
|
38,351
|
72,131
|
78,890
|
Accretion of contingent consideration |
|
|
419
|
306
|
(Gain) loss on disposition of assets |
2
|
138
|
62
|
(2,303)
|
Deferred income tax expense (benefit) |
|
|
59,305
|
(17,126)
|
Expenses not requiring cash |
|
|
(5,226)
|
(5,308)
|
Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
Accounts and notes receivable |
|
|
22,319
|
39,683
|
Accrued income taxes |
|
|
(3,985)
|
(1,236)
|
Other assets |
|
|
(2,992)
|
(7,352)
|
Accounts payable and accrued liabilities |
|
|
(6,862)
|
14,763
|
Net cash provided by operating activities |
|
|
602
|
103,093
|
Cash flows from investing activities: |
|
|
|
|
Capital expenditures |
|
|
(16,257)
|
(54,605)
|
Proceeds from the sale of assets |
|
|
1,387
|
288
|
Proceeds from insurance settlements |
|
|
0
|
2,500
|
Payments to Acquire Businesses, Net of Cash Acquired |
|
|
0
|
10,431
|
Net cash used in investing activities |
|
|
(14,870)
|
(62,248)
|
Cash flows from financing activities: |
|
|
|
|
Repayments of long-term debt |
|
|
|
(30,000)
|
Paydown on term note |
|
|
0
|
(30,000)
|
Payment of debt issuance costs |
|
|
0
|
(1,359)
|
Payment for noncontrolling interest |
|
|
3,375
|
0
|
Payments of contingent consideration |
|
|
(6,000)
|
0
|
Excess tax benefit from stock-based compensation |
|
|
(1,617)
|
(999)
|
Intercompany advances, net |
|
|
0
|
0
|
Net cash used in financing activities |
|
|
(10,992)
|
(32,358)
|
Net increase (decrease) in cash and cash equivalents |
|
|
(25,260)
|
8,487
|
Cash and cash equivalents, beginning of year |
|
116,943
|
134,294
|
108,456
|
Cash and cash equivalents, end of period |
109,034
|
116,943
|
109,034
|
116,943
|
Provision for reduction in carrying value of certain assets |
0
|
2,316
|
0
|
2,316
|
Loss on debt modification |
|
|
(1,088)
|
0
|
Parent [Member] |
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
Net loss |
(39,824)
|
(14,029)
|
(135,657)
|
(10,807)
|
Adjustments to reconcile net income (loss) |
|
|
|
|
Depreciation and amortization |
0
|
0
|
0
|
0
|
Accretion of contingent consideration |
|
|
0
|
0
|
(Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
Deferred income tax expense (benefit) |
|
|
(49,167)
|
22,414
|
Expenses not requiring cash |
|
|
(2,693)
|
(4,039)
|
Equity in net earnings of subsidiaries |
24,568
|
8,392
|
40,793
|
(597)
|
Accounts and notes receivable |
|
|
0
|
0
|
Accrued income taxes |
|
|
21,711
|
2,146
|
Other assets |
|
|
(103,035)
|
(77,427)
|
Accounts payable and accrued liabilities |
|
|
3,281
|
29
|
Net cash provided by operating activities |
|
|
(119,959)
|
(105,031)
|
Cash flows from investing activities: |
|
|
|
|
Capital expenditures |
|
|
0
|
0
|
Proceeds from the sale of assets |
|
|
0
|
0
|
Proceeds from insurance settlements |
|
|
|
0
|
Payments to Acquire Businesses, Net of Cash Acquired |
|
|
|
0
|
Net cash used in investing activities |
|
|
0
|
0
|
Cash flows from financing activities: |
|
|
|
|
Repayments of long-term debt |
|
|
|
(30,000)
|
Payment of debt issuance costs |
|
|
|
(1,359)
|
Payment for noncontrolling interest |
|
|
3,375
|
|
Payments of contingent consideration |
|
|
0
|
|
Excess tax benefit from stock-based compensation |
|
|
(1,617)
|
(999)
|
Intercompany advances, net |
|
|
106,246
|
142,814
|
Net cash used in financing activities |
|
|
101,254
|
110,456
|
Net increase (decrease) in cash and cash equivalents |
|
|
(18,705)
|
5,425
|
Cash and cash equivalents, beginning of year |
|
42,153
|
73,985
|
36,728
|
Cash and cash equivalents, end of period |
55,280
|
|
55,280
|
|
Provision for reduction in carrying value of certain assets |
|
|
|
0
|
Loss on debt modification |
|
|
1,088
|
|
Guarantor [Member] |
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
Net loss |
(16,502)
|
(7,187)
|
(30,816)
|
(4,868)
|
Adjustments to reconcile net income (loss) |
|
|
|
|
Depreciation and amortization |
23,314
|
23,958
|
46,439
|
47,268
|
Accretion of contingent consideration |
|
|
419
|
0
|
(Gain) loss on disposition of assets |
(209)
|
6
|
(153)
|
(45)
|
Deferred income tax expense (benefit) |
|
|
(9,569)
|
(6,574)
|
Expenses not requiring cash |
|
|
282
|
(441)
|
Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
Accounts and notes receivable |
|
|
7,755
|
27,778
|
Accrued income taxes |
|
|
(17,830)
|
229
|
Other assets |
|
|
102,496
|
59,964
|
Accounts payable and accrued liabilities |
|
|
(5,737)
|
14,890
|
Net cash provided by operating activities |
|
|
111,860
|
152,231
|
Cash flows from investing activities: |
|
|
|
|
Capital expenditures |
|
|
(7,499)
|
(37,794)
|
Proceeds from the sale of assets |
|
|
121
|
82
|
Proceeds from insurance settlements |
|
|
|
0
|
Payments to Acquire Businesses, Net of Cash Acquired |
|
|
|
10,431
|
Net cash used in investing activities |
|
|
(7,378)
|
(48,143)
|
Cash flows from financing activities: |
|
|
|
|
Repayments of long-term debt |
|
|
|
0
|
Payment of debt issuance costs |
|
|
|
0
|
Payment for noncontrolling interest |
|
|
0
|
|
Payments of contingent consideration |
|
|
(6,000)
|
|
Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
Intercompany advances, net |
|
|
(100,144)
|
(97,138)
|
Net cash used in financing activities |
|
|
(106,144)
|
(97,138)
|
Net increase (decrease) in cash and cash equivalents |
|
|
(1,662)
|
6,950
|
Cash and cash equivalents, beginning of year |
|
20,496
|
13,854
|
13,546
|
Cash and cash equivalents, end of period |
12,192
|
|
12,192
|
|
Provision for reduction in carrying value of certain assets |
|
|
|
0
|
Loss on debt modification |
|
|
0
|
|
Non-Guarantor [Member] |
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
Net loss |
(8,064)
|
(1,110)
|
(9,977)
|
6,116
|
Adjustments to reconcile net income (loss) |
|
|
|
|
Depreciation and amortization |
13,003
|
14,393
|
25,692
|
31,622
|
Accretion of contingent consideration |
|
|
0
|
306
|
(Gain) loss on disposition of assets |
211
|
132
|
215
|
(2,258)
|
Deferred income tax expense (benefit) |
|
|
(569)
|
1,286
|
Expenses not requiring cash |
|
|
7,637
|
(828)
|
Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
Accounts and notes receivable |
|
|
14,564
|
11,905
|
Accrued income taxes |
|
|
(7,866)
|
(3,611)
|
Other assets |
|
|
(2,453)
|
10,111
|
Accounts payable and accrued liabilities |
|
|
(4,406)
|
(156)
|
Net cash provided by operating activities |
|
|
8,701
|
55,893
|
Cash flows from investing activities: |
|
|
|
|
Capital expenditures |
|
|
(8,758)
|
(16,811)
|
Proceeds from the sale of assets |
|
|
1,266
|
206
|
Proceeds from insurance settlements |
|
|
|
2,500
|
Payments to Acquire Businesses, Net of Cash Acquired |
|
|
|
0
|
Net cash used in investing activities |
|
|
(7,492)
|
(14,105)
|
Cash flows from financing activities: |
|
|
|
|
Repayments of long-term debt |
|
|
|
0
|
Payment of debt issuance costs |
|
|
|
0
|
Payment for noncontrolling interest |
|
|
0
|
|
Payments of contingent consideration |
|
|
0
|
|
Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
Intercompany advances, net |
|
|
(6,102)
|
(45,676)
|
Net cash used in financing activities |
|
|
(6,102)
|
(45,676)
|
Net increase (decrease) in cash and cash equivalents |
|
|
(4,893)
|
(3,888)
|
Cash and cash equivalents, beginning of year |
|
54,294
|
46,455
|
58,182
|
Cash and cash equivalents, end of period |
41,562
|
|
41,562
|
|
Provision for reduction in carrying value of certain assets |
|
2,316
|
|
(2,316)
|
Loss on debt modification |
|
|
0
|
|
Consolidation, Eliminations [Member] |
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
Net loss |
24,568
|
8,392
|
40,793
|
(597)
|
Adjustments to reconcile net income (loss) |
|
|
|
|
Depreciation and amortization |
0
|
0
|
0
|
0
|
Accretion of contingent consideration |
|
|
0
|
0
|
(Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
Deferred income tax expense (benefit) |
|
|
0
|
0
|
Expenses not requiring cash |
|
|
0
|
0
|
Equity in net earnings of subsidiaries |
(24,568)
|
(8,392)
|
(40,793)
|
597
|
Accounts and notes receivable |
|
|
0
|
0
|
Accrued income taxes |
|
|
0
|
0
|
Other assets |
|
|
0
|
0
|
Accounts payable and accrued liabilities |
|
|
0
|
0
|
Net cash provided by operating activities |
|
|
0
|
0
|
Cash flows from investing activities: |
|
|
|
|
Capital expenditures |
|
|
0
|
0
|
Proceeds from the sale of assets |
|
|
0
|
0
|
Proceeds from insurance settlements |
|
|
|
0
|
Payments to Acquire Businesses, Net of Cash Acquired |
|
|
|
0
|
Net cash used in investing activities |
|
|
0
|
0
|
Cash flows from financing activities: |
|
|
|
|
Repayments of long-term debt |
|
|
|
0
|
Payment of debt issuance costs |
|
|
|
0
|
Payment for noncontrolling interest |
|
|
0
|
|
Payments of contingent consideration |
|
|
0
|
|
Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
Intercompany advances, net |
|
|
0
|
0
|
Net cash used in financing activities |
|
|
0
|
0
|
Net increase (decrease) in cash and cash equivalents |
|
|
0
|
0
|
Cash and cash equivalents, beginning of year |
|
$ 0
|
0
|
0
|
Cash and cash equivalents, end of period |
$ 0
|
|
0
|
|
Provision for reduction in carrying value of certain assets |
|
|
|
$ 0
|
Loss on debt modification |
|
|
$ 0
|
|